Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Insulet Corporation - Common Stock
(NQ:
PODD
)
248.61
-9.46 (-3.67%)
Streaming Delayed Price
Updated: 10:18 AM EST, Feb 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Insulet Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
PODD Q4 Deep Dive: Type 2 Diabetes Expansion and Innovation Drive Outperformance
Today 0:31 EST
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 31.2% year on year to $783.8 million. The company...
Via
StockStory
What's going on in today's session: S&P500 movers
↗
February 18, 2026
Via
Chartmill
Insulet (PODD) Shares Skyrocket, What You Need To Know
February 18, 2026
Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) jumped 5.6% in the afternoon session after the company posted strong fourth-quarter 2025 financial results that beat Wall Street's...
Via
StockStory
Topics
Artificial Intelligence
Supply Chain
Insulet (PODD) Shakes the Market with Q4 Earnings Beat as Omnipod 5 Dominance Continues
February 18, 2026
Insulet Corporation (NASDAQ:PODD) delivered a commanding performance in its fourth-quarter earnings report released today, February 18, 2026. The medical device leader announced an adjusted earnings...
Via
MarketMinute
Topics
Earnings
Insulet Corp. (NASDAQ:PODD) Reports Strong Q4 Earnings Beat Amid Mixed 2026 Guidance
↗
February 18, 2026
Via
Chartmill
Topics
Earnings
Wednesday's session: gap up and gap down stock in the S&P500 index
↗
February 18, 2026
Via
Chartmill
What's going on in today's pre-market session: S&P500 movers
↗
February 18, 2026
Via
Chartmill
Insulet (NASDAQ:PODD) Surprises With Q4 CY2025 Sales
February 18, 2026
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 31.2% year on year to $783.8 million. The company expects...
Via
StockStory
Insulet Corp (NASDAQ:PODD): A Prime GARP Candidate in Diabetes Care
↗
February 17, 2026
Via
Chartmill
Earnings To Watch: Insulet (PODD) Reports Q4 Results Tomorrow
February 16, 2026
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting earnings this Wednesday morning. Here’s what to look for.
Via
StockStory
Topics
Government
World Trade
Insulet Corp (NASDAQ:PODD) Matches Key Growth Rules in Navellier's "Little Book" Strategy
↗
February 04, 2026
Via
Chartmill
Insulet Corp (NASDAQ:PODD) Passes Key Growth Screen with Strong Momentum
↗
January 14, 2026
Via
Chartmill
3 Profitable Stocks for Long-Term Investors
February 10, 2026
Companies with solid operating margins have a competitive edge, allowing them to reinvest for sustainable expansion. The best of these businesses balance profitability with reinvestment, setting...
Via
StockStory
2 Cash-Producing Stocks with Impressive Fundamentals and 1 Facing Challenges
February 08, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via
StockStory
2 S&P 500 Stocks to Research Further and 1 Facing Challenges
February 01, 2026
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...
Via
StockStory
Topics
Stocks
Exploring the top movers within the S&P500 index during today's session.
↗
January 23, 2026
Via
Chartmill
Which S&P500 stocks are moving on Friday?
↗
January 23, 2026
Via
Chartmill
1 Safe-and-Steady Stock with Impressive Fundamentals and 2 We Find Risky
January 20, 2026
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Via
StockStory
Is Insulet (PODD) the Future of Diabetes Management?
↗
January 20, 2026
Join us as we evaluate Insulet's potential in the diabetes management market. With a unique product offering and strong growth, could this stock be your next big investment?
Via
The Motley Fool
What's going on in today's session: S&P500 gap up and gap down stocks
↗
January 09, 2026
Via
Chartmill
Precision Medicine and the Tubeless Revolution: An In-Depth Look at Insulet Corporation (PODD)
January 09, 2026
Today’s Date: January 9, 2026 Introduction In the rapidly evolving landscape of medical technology, few companies have managed to fundamentally reshape a multi-decade standard of care as successfully...
Via
PredictStreet
Topics
Economy
Product Recall
World Trade
Which S&P500 stocks are showing activity after the closing bell on Wednesday?
↗
January 07, 2026
Via
Chartmill
Stay updated with the stocks that are on the move in today's after-hours session.
↗
January 07, 2026
Via
Chartmill
Get insights into the top movers in the S&P500 index of Wednesday's pre-market session.
↗
January 07, 2026
Via
Chartmill
3 Healthcare Stocks with Exciting Potential
January 06, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their...
Via
StockStory
Topics
Stocks
2 Mid-Cap Stocks to Own for Decades and 1 That Underwhelm
December 30, 2025
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with...
Via
StockStory
Topics
Artificial Intelligence
Insulet Corp (NASDAQ:PODD) Presents a Classic Growth at a Reasonable Price (GARP) Case
↗
December 29, 2025
Insulet Corp (PODD) exemplifies Growth at a Reasonable Price (GARP) with strong earnings growth, solid financials, and a valuation justified by its sector and future potential.
Via
Chartmill
Insulet Corp (NASDAQ:PODD) Passes Key Growth Stock Screen from "The Little Book That Makes You Rich"
↗
December 23, 2025
Insulet Corp (PODD) exemplifies a high-growth stock, meeting key criteria for accelerating earnings, sales, and cash flow with strong profitability.
Via
Chartmill
Patient Monitoring Stocks Q3 In Review: Insulet (NASDAQ:PODD) Vs Peers
December 08, 2025
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Friday's session: top gainers and losers in the S&P500 index
↗
December 05, 2025
Let's delve into the developments on the US markets one hour before the close of the markets on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
